ANALYST RECOMMENDATIONS : Biogen, Booking, GSK, Papa John's, XPO...

Every morning, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information can be used to shed light on movements in certain stocks or on market sentiment towards a company.

• Ametek: Seaport Global Securities initiated coverage with a recommendation of buy. PT set to $195.
• BAE Systems: Barclays remains Overweight with price target raised from 2020 to 1250 GBp.
• Biogen: Oppenheimer & Co cut the target on Biogen Inc. to $290 from $360. Maintains outperform rating.
• Booking: Argus Research Corp raised the target to $3,677 from $3,080. Maintains buy rating.
• DaVita: UBS raised the recommendation on DaVita Inc. to buy from neutral. 
• DS Smith: Barclays resumes coverage with in line rating, targeting GBp 310.
• FirstEnergy: UBS cut its recommendation to neutral from buy. PT up 10% to $40.
• GSK: LBW remains Buy with a price target reduced from 1700 to 1600 GBp.
• Haleon: Investec upgrades from sell to hold, targeting GBp 320.
• Informa: Goldman Sachs remains Buy with a price target raised from 892 to 986 GBp.
• International flavors: Stifel downgrades to hold from buy. PT up 5.8% to $85.
• Mondi: Barclays resumes coverage with in line rating,  targeting GBp 1300.
• Papa John's: CFRA downgrades to sell from hold. PT down 14% to $70.
• Pearson: Goldman Sachs remains Buy with price target raised from 2115 to 1176 GBp.
• Rolls-Royce: Citigroup remains Buy with a price target raised from GBp 255 to GBp 294.
• WPP: Deutsche Bank downgrades from buy to hold, targeting GBp 1030.
• XPO: UBS raised the target to $83 from $71. Maintains buy rating.